A new study in Clinical Epidemiology and Global Health features the Glivec®Patient Assistance Program (GIPAP) and reveals that "chronic myelocytic leukemia (CML) is diagnosed at an earlier age in poorer populations than in more affluent populations." The study focused on India's CML population to investigate other possible contributors to early age at onset. The team of authors include our very own South Asia Region Head Viji Venkatesh, and Max CEO Pat Garcia-Gonzalez, as well as Paul H. Levine, Kunal Ajmera, Brenna O’Neill, Heather J. Hoffman. The study is only available to the public for a limited time so if you know a physician...Read More
Follow the Patient JourneyJoin Rosario as she shares her journey from cancer patient to advocate and leader.
See Rosario's Journey